CClinicalTrials.gg
CompletedNCT03585868COFREUpdated Jul 13, 2018

Effects of COcoa Supplement in FRail Elderly Subjects (COFRE)

An interventional study of Placebo and Flavonoids in Sarcopenia and Frail Elderly Syndrome, sponsored by National Polytechnic Institute, Mexico. Completed. Open to participants aged 55 Years to 90 Years. Per ClinicalTrials.gov, last updated 2018-07-13.

Sponsored by National Polytechnic Institute, Mexico · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Jan 2017, registered May 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
55 Years to 90 Years
Sex
All
01

Study summary

The study use a double blind, placebo-controlled design enrolling male and female subjects between 55-90 yo to evaluate the effect of daily consumption of a cocoa beverage on anthropometric, metabolic, oxidative stress, physical performance and quality of life.

Read the detailed description

The study use a double blind, placebo-controlled design enrolling male and female subjects between 55-90 yo randomly assigned to consumption of a flavonoid rich mixture (flavonoids; F), alkalinized cocoa which eliminates flavonoid content (no flavonoids; NF) or placebo. All beverages had similar physical characteristics and flavor. Cocoa beverages were provided in individual sachets containing a dry powder that was reconstituted with water just before consumption. Subjects were instructed as above to maintain their usual lifestyle, to limit intake of high caloric foods and flavonoid-containing foods and beverages, and to walk for 30 min/day.

To determine the effect of flavonoids, study evaluates anthropometric measures, metabolic parameters as glycemia and a lipid profile (triglycerides, total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol). To evaluate oxidative stress damage as lipid oxidation is measured with the malondialdehyde (MDA) assay. Protein carbonylation is measured using an assay for detection of carbonyl groups that relies on 2,4-dinitrophenylhydrazine (DNPH) as a substrate. The investigators also evaluate interleukin-6 and tumor necrosis factor levels.

For physical performance is evaluated the handgrip strength, and mobility assesment with the following test: Six-minute walk test, two-minute step, sit-up test and the up \& go test.

The investigators also assessed quality of life using the Health Related QoL (EQ-5D) questionnaire.

02

Conditions studied

  • Sarcopenia
  • Frail Elderly Syndrome

Browse trials for

Keywords

  • flavonoids
03

In context

Sarcopenia

1,208 studies on the registry are indexed under Sarcopenia; 402 are open to participants now.

This study's enrollment of 30 is below the median of 60 across 775 interventional studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

National Polytechnic Institute, Mexico is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Sex: both
  • Age: 55-90 yo
  • Waist circumference: Women > 80 cm, Men > 90 cm
  • HDL-c: Women \< 50 mg/dL, Men \< 40 mg/dL
  • Triglycerides: ≥ 150 mg/dL
  • Glycemia: ≈100 mg/dL
  • Hand strength: Women\< 20 kg, Men \< 30 kg
  • Up \& Go test: > 10 seconds

Non-inclusion criteria:

  • Any active infections
  • Malignancies
  • Habitual consumers of antioxidant supplements and cocoa products
  • Use of benzodiazepines or protein supplements
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
30 participants (actual)

Study arms

  • Placebo comparator
    Placebo

    Beverage without flavonoids

    Other: Placebo

  • Sham comparator
    No Flavonoids

    Beverage with alkalinized cocoa which eliminates flavonoid content

    Dietary Supplement: No Flavonoids

  • Experimental
    Flavonoids

    Beverage with a flavonoid rich mixture

    Other: Flavonoids

Interventions

  • OtherPlacebo

    Beverage with no flavonoids

  • OtherFlavonoids

    Flavonoids-enriched cacao beverage

  • Dietary supplementNo Flavonoids

    Beverage with alkalinized cocoa which eliminates flavonoid content

06

What researchers measure

Primary outcomes

  1. Blood glucose

    Fasting blood level

    Time frame: At 90 days

  2. Serum triacylglycerol concentration

    Fasting blood level

    Time frame: At 90 days

  3. Serum total cholesterol

    Fasting blood level

    Time frame: At 90 days

  4. Serum HDL cholesterol

    Fasting blood level

    Time frame: At 90 days

  5. Serum LDL cholesterol

    Fasting blood level

    Time frame: At 90 days

  6. Lipid oxidation

    Serum malondialdehyde Levels

    Time frame: At 90 days

  7. Protein oxidation

    Serum protein carbonylation Levels

    Time frame: At 90days

Secondary outcomes

  1. Handgrip strength

    Measures static force in kilograms that the hand can squeeze around a dynamometer

    Time frame: At 60 days

  2. Up and go test

    Measures time in seconds, a subject can rise and walk a 3-meter line and return to sit down

    Time frame: At 60 days

  3. Six-minute walk test

    Measures maximum distance in meters, a subject can walk at their normal gait and pace during 6 minutes

    Time frame: 6 minutes

  4. Two-minute step in place test

    Measures number of times a subject can rise each knee to the hip level during 2 minutes.

    Time frame: 2 minutes

  5. Sit-up test

    Measures number of times a subject can rise and sit-down in place during 30 seconds

    Time frame: 30 seconds

  6. EQ-5D questionnaire

    Self-administered health index that explores five domains

    Time frame: At 60 days

  7. Analog Visual Scale

    Use of a Analog Visual Scale to measure the quality of life, graded 0 (worst) to 100 (best) for the perception of wellbeing.

    Time frame: At 60 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Munguia L, Rubio-Gayosso I, Ramirez-Sanchez I, Ortiz A, Hidalgo I, Gonzalez C, Meaney E, Villarreal F, Najera N, Ceballos G. High Flavonoid Cocoa Supplement Ameliorates Plasma Oxidative Stress and Inflammation Levels While Improving Mobility and Quality of Life in Older Subjects: A Double-Blind Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2019 Sep 15;74(10):1620-1627. doi: 10.1093/gerona/glz107. PubMed 31056655 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03585868
Lead sponsor
National Polytechnic Institute, Mexico
Responsible party
Guillermo Ceballos Reyes (Professor, National Polytechnic Institute, Mexico) — Principal investigator
First posted
Jul 13, 2018
Start date
Jan 2017
Primary completion
Oct 2017
Completion
Dec 2017
Last update
Jul 13, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion